RICARDO ALONSO-ZALDIVAR
Bloomberg Businessweek
June 1, 2011
Federal investigators say they are starting to target individual executives in health care fraud cases previously aimed at impersonal corporations.
It’s raising the stakes for corporate honchos at drug companies, medical device manufacturers, nursing home chains and others who deal with Medicare and Medicaid.
Previously, if a company got caught, its lawyers in many cases would be able to negotiate a financial settlement. The company would write the government a big check and promise not to break the rules again.
The Emergency Election Sale is now live! Get 30% to 60% off our most popular products today!